Neoadjuvant nivolumab alone or in combination with relatlimab or ipilimumab in resectable head and neck squamous cell carcinoma (HNSCC).Robert L. Ferris, Dan P. Zandberg, Seungwon Kim et al.|Journal of Clinical Oncology|2023Cited by 17
Association of Patient and Tumor Characteristics With Outcomes in Young Head and Neck Squamous Cell Carcinoma PatientsRonan W. Hsieh, Dan P. Zandberg, William E. Gooding et al.|Clinical Otolaryngology|2024Cited by 4